MIFEPRISTONE oral

Prescription under medical supervision


Therapeutic action

– Antiprogestogen

Indications

– Termination of intra-uterine pregnancy up to 22 weeks after the last menstrual period, in combination with misoprostol

Forms and strengths

– 200 mg tablet

Dosage and duration

– 200 mg single dose, followed by the administration of misoprostol 1 to 2 days later

Contra-indications, adverse effects, precautions

– Do not administer to patients with chronic adrenal failure or severe uncontrolled asthma.
– May cause: gastrointestinal disturbances, vaginal bleeding, uterine contractions, headache.
– Breast-feeding: no contra-indication for a single dose; to be avoided if multiple doses

Remarks

– Do not use mifepristone in ectopic or molar pregnancy.
  Storage: below 25 °C -  -